Oruka Therapeutics ORKA
NASDAQ ORKA
$84.02 +0.60 (+0.72%)
As of: Oct 2, 2026 · 3:40 PM EDT

Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Oruka Therapeutics' Depreciation & Amortization (CF) was $43,000 in Q2 2026, up 126.3% from $19,000 a year earlier and unchanged from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Oruka Therapeutics' Depreciation & Amortization (CF) was $134,000 through Jun 30, 2026, up 148.1% year-over-year; for FY2025, it was $83,000, up 207.4% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 59.7% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $27,000 in FY2024 (+80.0%), $15,000 in FY2023 (-25.0%), $20,000 in FY2022 (+25.0%) and $16,000 in FY2021 (+100.0%).
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for three straight quarters, with growth averaging 295.0% over the last six quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q2 2025 (growth of 533.3%); the worst was Q4 2023 (a decline of 40.0%).
  • Per Business Quant data, ORKA's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $43,000 (Q1 2026), $28,000 (Q4 2025) and $20,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Oruka Therapeutics 5.24 Bn 3.29 Bn - 43,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43,000.00
Mar 31, 2026 43,000.00
Dec 31, 2025 28,000.00
Sep 30, 2025 20,000.00
Jun 30, 2025 19,000.00
Mar 31, 2025 16,000.00
Dec 31, 2024 16,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 3,000.00
Dec 31, 2023 3,000.00
Sep 30, 2023 4,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 4,000.00
Dec 31, 2022 5,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 6,000.00
Mar 31, 2022 5,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 5,000.00
Jun 30, 2021 3,000.00
API Access

Oruka Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ORKA&period=max&api_key=YOUR_API_KEY